ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials

The profiling and monitoring of immune responses are key elements in the evaluation of the efficacy and development of new biotherapies, and a number of assays have been introduced for analyzing various immune parameters before, during, and after immunotherapy. The choice of immune assays for a give...

詳細記述

書誌詳細

主要な著者:	Thomas J. Sayers, Michael R. Shurin, Kimberly Dunham, Susan Strobl, Anatoli M. Malyguine
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2012-05-01
シリーズ:	Cells
主題:	ELISPOT cancer clinical trial IFN-g Granzyme B Perforin cytotoxicity T cell
オンライン･アクセス:	http://www.mdpi.com/2073-4409/1/2/111
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!